CABLES2 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
Comparison | Statistical significance |
Normal-vs-Primary | 3.75509956462849E-10 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
4.04860000000618E-05 |
Normal-vs-Stage2 |
5.305600E-02 |
Normal-vs-Stage3 |
1.121190E-03 |
Normal-vs-Stage4 |
9.860200E-02 |
Stage1-vs-Stage2 |
5.179800E-01 |
Stage1-vs-Stage3 |
5.921700E-02 |
Stage1-vs-Stage4 |
5.121000E-01 |
Stage2-vs-Stage3 |
4.192800E-01 |
Stage2-vs-Stage4 |
9.860000E-01 |
Stage3-vs-Stage4 |
4.828800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
9.4616999790631E-09 |
Normal-vs-AfricanAmerican |
2.219000E-03 |
Normal-vs-Asian |
1.829650E-02 |
Caucasian-vs-AfricanAmerican |
4.842800E-01 |
Caucasian-vs-Asian |
4.595000E-01 |
AfricanAmerican-vs-Asian |
3.187400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
1.3029000001108E-07 |
Normal-vs-Female |
3.87549999980585E-07 |
Male-vs-Female |
3.486500E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
Descriptions |
Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Normal_Weight |
2.744100E-03 |
Normal-vs-Extreme_Weight |
1.641240E-03 |
Normal-vs-Obese |
1.5530799999941E-05 |
Normal-vs-Extreme_Obese |
9.781000E-01 |
Normal_Weight-vs-Extreme_Weight |
5.728200E-01 |
Normal_Weight-vs-Obese |
1.647410E-01 |
Normal_Weight-vs-Extreme_Obese |
2.277700E-02 |
Extreme_Weight-vs-Obese |
3.143800E-02 |
Extreme_Weight-vs-Extreme_Obese |
4.020400E-02 |
Obese-vs-Extreme_Obese |
6.446100E-04 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
5.95289999999471E-05 |
Normal-vs-Age(41-60Yrs) |
3.16079995510421E-09 |
Normal-vs-Age(61-80Yrs) |
1.178620E-04 |
Normal-vs-Age(81-100Yrs) |
9.584400E-01 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.110100E-02 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.083800E-03 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.814200E-04 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.291800E-02 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.402300E-02 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.733190E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-VS-Type1 PRCC |
2.66989996777767E-09 |
Normal-VS-Type2 PRCC |
3.699600E-01 |
Normal-VS-KIRP CIMP |
1.057800E-03 |
Normal-VS-Unclassified PRCC |
2.955700E-04 |
Type1 PRCC-VS-Type2 PRCC |
2.199700E-04 |
Type1 PRCC-VS-KIRP CIMP |
1.045800E-04 |
Type1 PRCC-VS-Unclassified PRCC |
2.454200E-01 |
Type2 PRCC-VS-KIRP CIMP |
1.318970E-03 |
Type2 PRCC-VS-Unclassified PRCC |
1.902100E-03 |
KIRP CIMP-VS-Unclassified PRCC |
1.603600E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
5.900200E-02 |
Normal-vs-N1 |
1.595680E-04 |
Normal-vs-N2 |
2.223000E-01 |
N0-vs-N1 |
1.137400E-03 |
N0-vs-N2 |
1.826560E-01 |
N1-vs-N2 |
4.095400E-01 |
|
|